BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ER, estrogen receptor AND Prognosis
287 results:

  • 1. Endometrial stromal tumors: A clinico-histomorphological spectrum of endometrial stromal tumors with review of literature.
    Verma A; Tomar R; Chaturvedi A; Dhankar N; Mallya V; Khurana N
    J Cancer Res Ther; 2024 Jan; 20(1):150-155. PubMed ID: 38554313
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
    Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
    World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer.
    Ding Y; Lv Z; Cao W; Shi W; He Q; Gao K
    Cell Death Dis; 2024 Jan; 15(1):65. PubMed ID: 38233384
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity.
    Wagh V; Menon S; Maheshwari A; Gupta S; Deodhar KK; Rekhi B
    Indian J Pathol Microbiol; 2023; 66(4):829-833. PubMed ID: 38084541
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
    Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
    Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of the role of endoplasmic reticulum stress genes in endometrial cancer and their association with tumor immunity.
    Zhang TA; Zhang Q; Zhang J; Zhao R; Shi R; Wei S; Liu S; Zhang Q; Wang H
    BMC Med Genomics; 2023 Oct; 16(1):261. PubMed ID: 37880674
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics.
    Liwei L; He L; Yibo D; Luyang Z; Zhihui S; Nan K; Danhua S; Junzhu W; Zhiqi W; Jianliu W
    World J Surg Oncol; 2023 Oct; 21(1):332. PubMed ID: 37865800
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
    Zhao L; Cheng YW; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Application of 18 F-FES PET in Clinical cancer Care : A Systematic Review.
    Huang YT; Chen TW; Chen LY; Huang YY; Lu YS
    Clin Nucl Med; 2023 Sep; 48(9):785-795. PubMed ID: 37482660
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [prognosis analysis of radical or modified radical hysterectomy and simple hysterectomy in patients with stage Ⅱ endometrial cancer].
    Zhai ZY; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jun; 58(6):442-450. PubMed ID: 37357603
    [No Abstract]    [Full Text] [Related]  

  • 11. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
    Nigon E; Lefeuvre-Plesse C; Martinez A; Chauleur C; Lortholary A; Favier L; Bats AS; Guille A; AdélaÏde J; Finetti P; de Casteljac V; Provansal M; Mamessier E; Bertucci F; Ray-Coquard I; Sabatier R
    J Transl Med; 2023 Jun; 21(1):408. PubMed ID: 37353806
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Distinct histological and clinical features associated with pure uterine serous carcinoma: A single institution experience.
    Zhi W; Zhan Y; He C; Jin Y
    Ann Diagn Pathol; 2023 Oct; 66():152173. PubMed ID: 37352704
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Casein kinase 1 controls the shuttling of epidermal growth factor receptor and estrogen receptor in endometrial carcinoma induced by breast cancer hormonal therapy: Relevance of GPER1/Src.
    Hoang LN; Lee SJ
    Cell Signal; 2023 Aug; 108():110733. PubMed ID: 37257767
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group].
    Karabajakian A; Genestie C; Meeus P; Guyon F; Llacer Moscardo C; Croce S; Taieb S; Duffaud F; Pautier P; Ray-Coquard I; Blay JY
    Bull Cancer; 2023; 110(7-8):836-843. PubMed ID: 37202293
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.
    Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
    Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease.
    Lien HE; Berg HF; Halle MK; Trovik J; Haldorsen IS; Akslen LA; Krakstad C
    EBioMedicine; 2023 Jun; 92():104595. PubMed ID: 37146405
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive cancers: Breast cancer, Cervical cancer, Endometrial cancer, Ovarian cancer and Prostate cancer.
    Korbecki J; Bosiacki M; Barczak K; Łagocka R; Brodowska A; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108425
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification.
    Perrone E; Capasso I; De Felice F; Giannarelli D; Dinoi G; Petrecca A; Palmieri L; Foresta A; Nero C; Arciuolo D; Lorusso D; Zannoni GF; Scambia G; Fanfani F
    Eur J Cancer; 2023 Jun; 186():98-112. PubMed ID: 37062213
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of uterine Carcinosarcoma and Its Association with Clinical Efficacy.
    Yagishita S; Nishikawa T; Yoshida H; Shintani D; Sato S; Miwa M; Suzuki M; Yasuda M; Ogitani Y; Jikoh T; Yonemori K; Hasegawa K; Hamada A
    Clin Cancer Res; 2023 Jun; 29(12):2239-2249. PubMed ID: 36976261
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
    Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
    BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.